Crop Life Science Limited Appoints Sheetalben Rachit Shah as Additional Independent Director
Crop Life Science Limited announced the appointment of Ms. Sheetalben Rachit Shah as an Additional (Independent) Director. The appointment was made by the Board of Directors during a meeting held on April 10, 2026, with immediate effect.The company confirmed that Ms. Sheetalben Rachit Shah (DIN: 11633798) has not been debarred from holding the office of Director by any order from the Securities and Exchange Board of India or other authorities.
The Board meeting commenced at 04:00 P. M. and concluded at 04:30 P. M.
Key details regarding the appointment of Ms. Sheetalben Rachit Shah are outlined below.
| Sr. No. | Detail of Event | Information Provided |
|---|---|---|
| 1 | Name of Director | Ms. Sheetalben Rachit Shah |
| 2 | Reason for Appointment | Ms. Sheetalben Rachit Shah (DIN: 11633798) was appointed as the Additional (Independent) Director of the Company. |
| 3 | Date and Terms of Appointment | April 10, 2026. She is appointed to hold office with effect from April 10, 2026, for a period of 5 (five) years, subject to regularization by shareholders. |
| 4 | Brief Profile | Ms. Sheetalben Rachit Shah is aged 38 years. She possesses strong management and leadership skills, with a proven ability to drive business growth and operational efficiency. Her extensive experience and strategic insight are anticipated to be valuable in guiding the Company's business decisions as an Independent Director. |
| 5 | Relationship Disclosure | NA |
Rajeshkumar Vrajlal Lunagariya, Managing Director, oversaw the announcement. Crop Life Science Limited is registered at 6th Floor ABS Tower, Near Chakli Circle, Old Padra Road, Vadodara - 390007 (Gujarat).
CLSL Stock Price Movement
Today, Crop Life Science Limited shares settled flat at ₹45.00, recording no change for the session. The stock closed with no marked movement, confirming its previous trading level after today’s activity.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.